Search

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

J
Jackson S. P. - Role of the Type Ia PI 3-kinase p110beta isoform in integrin alpha(IIb)beta(3) bi-directional signaling
Jackson K. W. - A novel plasma proteinase that enhances incorporation of a2-antiplasmin into fibrin
Jackson S. - Signaling events underlying thrombus formation
Jackson S. P. - A novel role for cytosolic calcium in down-regulating integrin aIIbb3 activation and platelet adhesiveness
  - Cytoskeletal regulation of the adhesive interactions between the platelet GPIb/V/IX receptor and von Willebrand factor
Jackson C. W. - aIIbb3 activation by botrocetin/vWf is ADP or TXA2 dependent and the resulting aIIbb3 outside-in signaling is the major trigger for subsequent granule release and TXA2 production
Jackson S. P. - Phosphoinositide 3-kinase beta (PI3Kb): a novel target for antithrombotic therapy
  - PLC g-dependent GPIb signaling following platelet adhesion to von Willebrand factor through a pathway distinct from FcR g chain and FcgRIIA
  - Mechanotransduction through glycoprotein Iba induces a unique series of morphologic changes in translocating platelets
Jackson E. C. G. - Streptococcus sanguis-induced platelet signal transduction pathways involve both ITAMs and ITIMs
Jackson S. P. - Integrin aIIbb3 outside-in calcium signals sustain platelet–fibrinogen interactions under flow
Jackson J. - Population prevalence of atrial fibrillation and factors associated with use of warfarin
  - Coagulation activation markers in atrial fibrillation: dose-dependent correlation with warfarin therapy
Jacob N. - Comparison of inherited and acquired thrombophilia in cerebral venous thrombosis and pulmonary embolism or deep vein thrombosis of the leg
Jacob M. - Smooth muscle cell recolonization of the aneurysmal thrombus is prevented by storage of leukocyte elastase in fibrin matrix
Jacob H. J. - Genetic and physical mapping of the platelet disorder in the fawn-hooded hypertensive rat
Jacoboson A. K. - Reliability of patient self-testing and point-of-care testing with the Harmony (TM) INR monitoring system: a 3-year study
Jacobs E. M. G. - Thrombophilia strikes at all ages
  - Effectiveness of excluding pulmonary embolism in the elderly by using a clinical decision rule and d-dimer
  - Screening of high factor VIII levels is not recommended in patients with recently diagnosed pulmonary embolism
Jacobs K. - A postoperative platelet count threshold contributes to an earlier diagnosis of heparin-induced thrombocytopenia and improved platelet recovery in cardiac surgery patients. The HITME (Heparin-Induced Thrombocytopenia Multicenter Evaluation) study
Jacobson A. - Maintenance of patient vs. professional competence with patient self testing of the INR – a 6-year experience
Jacobson A. - Precision of INR (International Normalized Ratio) measurement using laboratory and point-of-care assays: Understanding the impact of system influence on patient management
Jacobson K. A. - The P2X1 receptor for ATP plays an essential role in platelet aggregation at high shear
Jacobson B. F. - HIV associated thrombocytopenia: a 3-year trend analysis at the Johannesburg Hospital
Jacobson L. J. - Factor VIII pharmacokinetics in young boys with hemophilia: novel measures for prophylaxis dosing
Jacobson A. - Equivalence of venous and capillary INR values determined with the new CoaguChek® PT.S-test on the CoaguChek® S system
  - Performance evaluation of the new CoaguChek® PT.S-test on the CoaguChek® S system
Jacoski M. V. - Evaluation of the point of care Helena ICHOR/Plateletworks® and the Accumetrics Ultegra® RPFA for assessment of platelet function inhibition by platelet GPIIb-IIIa antagonists
Jacquelin B. - A study of gene expression profiles during megakaryocytopoiesis
Jacquelin B. - Repression of integrin a1 gene (ITGA1) expression in human megakaryocytes coincides with DNA methylation of the core promoter
Jacquemin M. - An anti-idiotypic mouse monoclonal antibody towards idiotopes of human anti-C2 inhibitors mimics C2 the 3D conformation of C2 and restores Factor VIII activity in vivo
  - The C1 domain substitution His2155Asp severely reduces factor VIII binding to von Willebrand factor
Jacquemin E. - Fatal intra cerebral hemorrhage due to severe vitamin K deficiency disclosing cystic fibrosis
Jacquemin M. - Deletion of residue Ala2201 in the factor VIII C2 domain impairs FVIII interactions with phospholipids and vWF and results in mild hemophilia A
Jacquemin M. - Response to DDAVP in mild/moderate hemophilia A patients according to the underlying factor VIII genotype
Jaeger J. E. - P-selectin-dependent lung colonization of melanoma cells is targeted by heparin treatment
Jaeken J. - Functional polymorphisms in the paternally expressed XLas and its cofactor ALEX decrease their mutual interaction and enhance receptor-mediated cAMP formation resulting in platelet Gs hyperfunction
Jaffer A. - Safety and efficacy of using Low-Molecular-Weight Heparins to bridge patients on long-term warfarin
Jagadeeswaran P. - Role of two populations of thrombocytes in arterial thrombosis in zebrafish
Jaikaran E. - Platelet CD109: evidence for a transmembrane homologue on monocytes?
Jaillon P. - Variations of INR and Factor VII Level are linked to Cytochrome P450 2C9 genotype
Jain N. - Pulmonary embolism in liver transplant setting associated with the use of solvent detergent plasma
Jairajpuri M. A. - Anti-thrombin III phenylalanines 122 and 121 contribute to its high affinity for heparin and conformational activation
Jakovljevic V. - Platelets–coronary endothelium interaction: focus on L-arginine:NO system
Jakubowski J. - Stereoselective inhibition of human platelet aggregation by R-138727, the active metabolite of CS-747, a novel P2Y12 receptor antagonist
Jalagadugula G. - Anti-platelet agents clopidogrel and aspirin inhibit expression of tissue factor procoagulant activity in patients with peripheral artery disease
Jaloma-Cruz A. - Clinical manifestation of severe hemophilia B ameliorated by Prothrombin 20210A
James N. J. - The influence of tissue factor (CD142) on endothelial cell apoptosis and proliferation
James P. - An ancient von Willebrand Disease (VWD) mutation that associates with a common haplotype in ~14% of type 1 VWD patients
James P. D. - The type 1/type 2M von Willebrand disease dilemma: findings from the Canadian Type 1 VWD study
James P. - Clear familial co-segregation of the type 1 von Willebrand disease phenotype and VWF haplotypes in the Canadian type 1 VWD study
James A. - Allelic frequencies of thrombophilic polymorphisms among African-Americans
James N. J. - Investigations on the regulation of vascular smooth muscle cell migration by tissue factor (CD142)
Janco R. L. - Utility of PFA-100 in pediatric patients referred for evaluation of bleeding symptoms
Janczak J. - Antiphospholipid antibodies in patients diagnosed for thrombophilia
Jandrot-Perrus M. - Glycoprotein Ib-mediated platelet activation: a signaling pathway evoked by thrombin
  - Integrin activation upon human platelet adhesion to collagen under flow
  - Thrombin regulates the expression of its cellular inhibitor protease nexin-1 in smooth muscle cells
  - Thrombospondin triggers P-selectin expression and phosphatidyl serine exposure on platelets
  - A deficiency of glycoprotein (GP) VI in platelets of a patient with gray platelet syndrome
  - Cross-talk between alpha2beta1 integrin and GPVI receptors regulates actin polymerization through Rho GTPase and MAP kinase Erk1/2 signaling pathways in human megakaryocytes
  - Specific phosphatidylserine exposure and microparticules shedding induced by a synthetic peptide
  - Platelet activation causes a metalloprotease-mediated down-regulation of GlycoproteinVI
Jándula B. M. - Self-management of oral anti-coagulation reduces the incidence of complications: preliminary results of the ACOA clinical trial
Janel N. - Effect of hyperhomocysteinemia on paraoxonase activity
Janiczek N. - Compound 48/80 inhibits thrombosis in balloon-injured arteries of hypercholesterolemic rabbits by inhibiting TF/FVIIa-mediated coagulation
Janisiw M. - Impact of platelet glycoprotein Ibalpha Kozak polymorphism on risk of ischemic cerebrovascular events
Janizewska G. - Biological and pharmacokinetic activity of the new recombinant thrombolytic and anthithrombotic agent RGD SAK-K2-HIR
Jankowski M. A. - Optimization of factor VIII clotting assays: evaluation of VWF content in FVIII-deficient plasma and effect of albumin in dilution buffer
Janning A. - Thrombospondin-1 promotes transendothelial migration of monocytes associated with platelets
Jansen F. H. - Elevated levels of d-dimer and fragment 1 + 2 upon central venous catheter insertion and factor V Leiden predict subclavian vein thrombosis
Janssen R. - IgG antiprothrombin antibodies from patients with antiphospholipid syndrome inhibit the inactivation of Factor Va by activated protein C
Janssen J. - Tc-99 m labelled modified recombinant tissue plasminogen activator uptake in acute deep venous thrombosis
Jardim H. - Association of MTHFR and ACE gene polymorphisms in reflux associated with renal damage
Jarutwachirakul W. - Prevalence of Arg 506 and Arg 306 mutations of the factor V gene in Thai blood donors
Jarvis G. E. - Collagen induces tyrosine phosphorylation of signaling proteins in Fc receptor g-chain-deficient platelets
Jarvis G. E. - Variation of GPVI levels in platelets: relationship to platelet function at high shear
Jarvis W. - Pulmonary embolism in liver transplant setting associated with the use of solvent detergent plasma
Jaursch-Hanke C. - Thrombin generation in platelet-rich plasma (PRP) is enhanced in patients with metabolic syndrome
Javen D. - Diagnostic utility of Simplify d-dimer – a new d-dimer test for patients with suspected venous thromboembolism
Jayandharan G. - Administration of gentamicin does not increase factor levels in severe hemophilia-B due to premature termination codons
Jayandharan G. - Factor IX gene deletions are a frequent cause of hemophilia B in India
Jaye D. L. - Extrahepatic synthesis of coagulation factor VII in prostate and breast cancer
Jazebi M. - Prevalence of activated protein C – resistance (APC-R) in patients with thromboembolic events: the first report from Iran
Jeanpierre E. - Tissue factor pathway in carotid atherosclerotic plaques: relationships with clinical patterns and risk factors
Jebeleanu G. - Genetic thrombophilia in Romanian women with pregnancy loss and pre-eclampsia
Jegaden O. - Anti-thrombotic treatment after coronary artery bypass graft surgery (CABGS):economic consequence of a change in regimen
Jenkins V. P. - In vitro expression study of two naturally occurring mutations (D141Y and C275S) of the von Willebrand factor (VWF) proeptide that result in defective multimerization and secretion
Jenkins A. H. - Whole blood thromboelastography and platelet function studies with DX-88, a Kunitz-type inhibitor of kallikrein
Jenkins P. V. - Evidence that interaction of the A2 domain of factor VIIIa with factor IXa occurs over an extended surface
Jenner W. J. - The use of the rotational thrombelastograph (ROTEG) in the quantification of the ‘lytic state’ during thrombolytic therapy: a comparative analysis in the subhuman primate
Jennings N. S. - Difference in binding of human and murine glycoprotein VI to collagen-related peptide and fibrillar collagen
Jennings I. - Results of d-dimer in the UK NEQAS (Blood Coagulation) proficiency testing program: Urgent need for improvements in Standardization of testing and reporting
Jennings I. - Diagnosis of factor XIII deficiency – room for improvement? Experience with the UK NEQAS (Blood Coagulation) proficiency testing programme
Jennings L. - Evaluation of the point of care Helena ICHOR/Plateletworks® and the Accumetrics Ultegra® RPFA for assessment of platelet function inhibition by platelet GPIIb-IIIa antagonists
Jennings I. - Possible causes of variation in INR results in UK NEQAS EQA program for Near Patient Testing/Point of Care devices
Jennings I. - Von Willebrand factor measurement in the UK NEQAS proficiency testing program
Jennings I. - Use of SSC/ISTH secondary standard to evaluate laboratory performance: A UK NEQAS for blood coagulation proficiency testing exercise
Jennings I. - Use of plasma spiked with monoclonal antibodies in lupus anticoagulant (LA) screening; experience with the UK NEQAS (Blood Coagulation) proficiency testing program
Jennings I. - Accuracy of laboratory diagnosis of familial thrombophilia, 2001–2002: UK NEQAS experience
  - Artificially depleted plasmas are suitable for proficiency testing of INR determination with some POC devices
  - An evaluation of four methods of external quality assurance (EQA) for patient self-management (PSM) of oral anti-coagulation: report on 97 patients
Jennings N. - Platelet glycoprotein VI has evolutionary conserved immunoglobulin domains, but a highly polymorphic stem and cytoplasmic domain
Jennings I. - SSC classification of hemophilia A: is it achievable? A UKNEQAS supplementary exercise
Jennings N. S. - Human glycoprotein VI: identification and blockade of the collagen-binding surface
Jensen H. K. - The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarction
Jensen H. P. - A comparison of survival rates at 8–10 years for hip-fracture patients given thromboprophylaxis with enoxaparin vs. unfractionated heparin
Jeon J. - Inhibitory mechanism of rat aortic vascular smooth muscle cell proliferation by NQ12, a novel antithrombotic agent
Jerczynska H. - Down-regulation of PAI-1 expression by natriuretic peptides is mediated by MAPK cascade in human endothelial cells
  - The role of vascular endothelial growth factor in an early phases of proangiogenic changes in human endothelial cells
Jerling J. C. - The effect of refined and red palm olein compared to sunflower oil on lipids and homeostatic factors in hyperfibrinogenemic patients
Jern S. - Coronary t-PA release is triggered by cardiac sympathetic nerve stimulation
Jern C. - Coronary t-PA release is triggered by cardiac sympathetic nerve stimulation
Jern S. - Increase in mitogenic and decrease in contractile P2 receptors in smooth muscle cells by fluid shear stress in intact human conduit vessels
  - Anti-hypertensive treatment restores impaired local fibrinolysis in essential hypertension
  - Quantification of ADP and ATP receptor expression in human platelets
Jerome S. - Effects of clopidogrel-aspirin combination vs. aspirin alone on platelet aggregation and major receptor expression in patients with heart failure. For the plavix use for treatment of congestive heart failure (PLUTO-CHF) trial
Jeske W. P. - Intimatan ameliorates the activation of human platelets by heparin/heparin antibody from patients with heparin-induced thrombocytopenia
Jeske W. - Platelet and inflammatory changes induced by angioplasty and brachytherapy
Jeske W. P. - A postoperative platelet count threshold contributes to an earlier diagnosis of heparin-induced thrombocytopenia and improved platelet recovery in cardiac surgery patients. The HITME (Heparin-Induced Thrombocytopenia Multicenter Evaluation) study
Jeske W. - Lack dose-response with Fondaparinux and Idraparinux is due to endogenous antithrombin saturation
Jeske W. P. - Pharmacodynamic profile of Intimatan as an antithrombotic agent for venous thrombosis
Jeske W. - Interaction of thrombolytic agents with argatroban: pharmacological implications
Jeske W. - Activation of neutrophils by antibodies generated in heparin-induced thrombocytopenia
Jeske W. - Non-coagulant variants of thrombin are capable of activating procarboxypeptidase U
Jeske W. P. - Statin regulation of extrinsic thrombin generation
Jesmok G. - Distinct dose-dependent effects of plasmin and TPA on coagulation and haemorrhage
Jespersen J. - European concerted action on anti-coagulation (ECAA). reliability of International Normalized Ratios (INR) from CoaguChek mini and TAS PT-NC whole blood point-of-care test monitor systems
  - European concerted action on anti-coagulation (ECAA). Correction of displayed INR on two point-of-care test (POCT) whole blood prothrombin time monitors (CoaguChek Mini and TAS PT-NC) by independent International Sensitivity Index (ISI) calibration
  - European action on anti-coagulation – cost effectiveness of computer assisted anti-coagulant dosage
Jeter M. L. - Effect of a RNA-thrombin aptamer on thrombin inhibition by antithrombin, heparin cofactor II and protein C inhibitor
Jetzl A. - High dose of atorvastatin does not effect levels of plasma tissue factor in patients with coronary artery disease
Jeziková A. - TAFI and diabetic nephropathy
Jiang X.-C. - The platelet adhesion receptor, F11R (a.k.a. JAM-1), is critical for the initiation of plaque formation, thrombosis and atherosclerosis
Jiao J. A. - Protection of a chimeric antihuman tissue factor monoclonal antibody against tissue factor-induced acute thrombosis in mice
  - A chimeric anti-human tissue factor antibody attenuates inflammatory responses in rhesus monkeys challenged with E. coli
  - Anti-metastatic effect of an anti-human tissue factor monoclonal antibody on human breast and prostate experimental metastasis models in nude mice
Jichuan S. - A study on the changes in of plasma coagulative, anti-coagulative, fibrinolytic activities in patients with cerebral infarction and the therapy with low molecular weight heparin
Jie A. F. H. - Clot penetration and fibrin binding of amediplase
Jilma B. - Changes in ADAMTS13 (vWF cleaving protease) activity after induced acute release of von Willebrand factor
Jilma B. - High prevalence of aspirin resistance in patients with acute coronary syndromes
Jimenez J. J. - Tissue factor activity is controlled by its inhibitor and redox state: Findings in endothelial microparticles, monocytes, and a porcine trauma model
Jimenez S. - Polymorphisms of platelet glycoproteins Ib-a and Ia/IIa: relationship with early arteriosclerosis and arterial thrombosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosus
Jimenez R. - Acquired platelet dysfunction with eosinophilia in children: A tropical disease present in Venezuela
Jin J. - Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, C17 and C270
Jin M. - Proteomic identification of tissue factor regulatory components in blood monocytes
Jin Y. - The anti-platelet activity of J78 is mediated mainly by inhibition of arachidonic acid metabolism
Jin J. - Human platelets generate thromboxane A2 upon interaction with immobilized fibrinogen without a requirement for adherence in a Syk-dependent manner
Jinca C. - Evaluation of the rFVIIa efficacy in children's haemorrhages of different etiology
Jirapradittha J. - Successful use of recombinant activated factor VII for controlling bleeding in patients receiving invasive surgeries
Jirouskova M. - A monoclonal antibody to the fibrinogen g chain alters clot structure and properties by producing thinner fibrin fibers arranged in bundles
  - P-Selectin deficiency results in impaired thrombus formation and frequent embolization in mouse model of carotid artery thrombosis
Joakimsen O. - Inflammation and endothelial dysfunction in patients with carotid stenosis
Jodo S. - Sensitivity of semiquantitative lupus anticoagulant test for the diagnosis of antiphospholipid syndrome
Johannessen M. - In vitro effect of recombinant activated factor VII on thrombin generation and clot formation in blood from patients on vitamin K-antagonist therapy
Johannessen M. - Hemophilia patients and the assessment of thrombin generation in platelet-rich plasma and platelet-poor plasma
Johansen K. - GH9001, a novel anti-thrombotic agent, is more effective than low-molecular-weight heparin, fondaparinux, or hirudin in rabbit models
Johansen K. B. - Comparison of TFPI release of various LMW heparins based on the molecular weight distribution of the LMW heparins and a model describing the TFPI release according to molecular mass
Johansen P. - Recombinant factor VIIa in management of acute CNS and GI bleedings during warfarin thromboprophylaxis: clinical and biochemical aspects
Johansson S. - Excretion of the oral direct thrombin inhibitor ximelagatran into breast milk following oral administration to breast-feeding women
Johansson M. C. - Clopidogrel treatment provides limited protection against exercise-induced platelet-leukocyte conjugation
Johansson S. - No influence of alcohol intake on the pharmacokinetics or pharmacodynamics of the oral direct thrombin inhibitor, ximelagatran, in healthy volunteers
Johansson M. C. - Platelet-leukocyte aggregation under shear stress: Differential involvement of selectins and integrins
Johansson M. - Enhanced platelet and leukocyte activation by strenuous exercise in type I diabetes mellitus
Johansson M.-C. - Platelet function and inflammatory markers in patients with type 1 diabetes with and without microvascular complications
Johansson M. - Enhanced leukocyte-platelet cross-talk in type 1 diabetes mellitus
Johansson A. - The molecular background to von Willebrand disease type 1 in Sweden
Johansson M.-C. - Clopidogrel treatment reduces platelet activity in vivo, but does not counteract exercise-induced platelet activation
Johansson M. C. - Acute hyperglycemia enhances platelet secretion but not platelet aggregation
Johe P. - The in vivo effect of melatonin on cellular activation processes in human blood during strenuous physical exercise
Johl J. - Incidental pulmonary embolism in patients with cancer
Johnell M. - The activation of inflammation and coagulation by different heparin surfaces
  - Formation of the catalytically active FVIIa/tissue factor complex leads to enhanced PDGF-BB-stimulated chemotaxis and IL-8 release in monocytes
Johnson J. A. - Low-molecular-weight heparin (LMWH) as bridging anticoagulation in patients who require temporary interruption of warfarin for elective surgery: assessment of a standardized perioperative anticoagulation regimen
Johnson D. J. D. - Role of Anti-thrombin residue Glu381 (P13)
Johnson B. D. - Lineage-specific correction of a hemorrhagic disorder affecting platelets: gene therapy for Glanzmann thrombasthenia
Johnson J. - A multinational observational cohort study in hospitalized medical patients of practices in prevention of venous thromboembolism and clinical outcomes: findings of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE)
Johnson G. J. - Intrasvascular tissue factor procoagulant activity increases following joint replacement surgery
Johnson J. A. - Peri-procedure management of patients with heart valve replacements who require temporary interruption of warfarin therapy using low-molecular-weight heparin (enoxaparin)
Johnson C. M. - Combined mechanical and pharmacologic thrombolysis for ilio-femoral deep venous thrombosis. Single center short-term outcomes
Johnson G. J. - Experimental studies of anorectic drug cardiovascular toxicity: oral fenfluramine decreases dog platelet serotonin uptake and content, elevates plasma serotonin and causes mild mitral valve regurgitation
  - P38 MAP kinase is rapidly phosphorylated via agonist-specific pathways in human and dog platelets, but its activation is not causally linked to secretion
Johnson F. - A phase I/II trial of AAV-mediated, liver-directed gene transfer for hemophilia B
Johnsson H. - Spiral computed tomography has a higher sensitivity and specificity than d-dimer in the diagnosis of acute pulmonary embolism
  - A comparison of spiral computed tomography and latex agglutination D-dimer assay in acute pulmonary embolism using pulmonary arteriography as Gold Standard
Johnston M. - Baseline thrombophilic markers do not predict deep venous thrombosis in medical–surgical ICU patients
  - The stability of 11-dehydro thromboxane B2 levels in random urine samples
  - The prevalence and prognostic importance of elevated cardiac troponins in patients with acute submassive pulmonary embolism
  - Levels of D-dimer do not predict deep venous thrombosis in medical–surgical ICU patients
Johnstone T. - A program for the point of care testing (POCT) of the ACT to ensure safe control of heparinization in coronary angioplasty
Johnstone S. - Molecular basis of the bleeding disorder caused by Prothrombin-Vancouver
Johri M. - Resource utilization and loss of productivity during the 4 months following a diagnosis of deep venous thrombosis
Joist J. H. - A new method for identification of false-negative testing for lupus anticoagulant due to contamination of test plasma by platelet-derived micropatricles
Jones D. W. - Preparations of beta-2 glycoprotein I contain plasma kallikrein
Jones G. - The bedside investigation of pulmonary embolism diagnosis (BIOPED) study- a triple blind randomized control trial comparing initial bedside diagnostic tests to standard care (initial V/Q scan) in the investigation of patients with suspected PE
Jones M. L. - Regulation of tyrosine phosphatase SHP-1 in human platelets by protein kinase C
Jones C. D. - Novel factor V mutations in three separate families resulting in factor V deficiency and bleeding
Jones D. W. - Urokinase induced fibrinolysis in thromboelastography (UKIFTEG): a new assay for determining fibrinolysis in whole blood
Jones C. I. - Different classes of contrast media affect the formation and subsequent lysis of thrombi formed in vitro in whole blood under conditions of flow
  - Prevention of thromboemboli by enhancing fibrinolysis: a possible therapeutic mechanism of action for Dextran-40
  - Resistance to fibrinolysis in arterial thrombi: the importance of platelets
Jones N. L. - A common mutation 4247T ® A (I1416N) causing type 2M von Willebrand disease in patients from three unrelated families previously diagnosed as severe type 1 VWD
Jones D. W. - Plasma fibrinogen, factor IIXa and other coronary heart disease risk factors in exercising and nonexercising men aged 30–45 years
Jones D. W. - Contact system activation, FXIIa and plasma kallikrein produce enhanced fibrinolysis in urokinase induced fibrinolysis in thromboelastography: (UKIFTEG)
Jones C. I. - The anti-platelet effect of aspirin is reduced following administration of heparin during carotid endarterectomy
Jones C. J. - Intrauterine growth retardation and recurrent pregnancy loss associated with prothrombin gene variants 20221C > T and 20209C > T
Jong G. - The roles of serum insulin-like growth factor and binding protein, human growth hormone, matrix metalloproteinases and interleukin-10 in coronary heart disease to heart failure
Jong G. P. - New diagnostic guideline for coronary heart disease in old people
Jorda M. - Effect of antiphospholipid antibodies in the activation of the contact complex: importance in the obstetric complications of the antipospholipid syndrome
Jordan P. A. - The inhibitory action of quercetin on GPVI-mediated platelet signaling and activation
Jordan P. A. - A role for the thiol isomerase protein P5 in platelet function
Jorg I. - Treatment of patients with a history of heparin-induced thrombocytopenia (HIT type II) and of anti-lepirudin antibodies with argatroban or lepirudin
  - Impact of direct thrombin inhibitors on actions of vitamin K antagonists on analysis with different coagulation parameters: aPTT and PT for argatroban, hirudin and melagatran
  - Inhibition of blood coagulation by ximelagatran in patients with a first episode of symptomatic acute deep venous thrombosis for prophylaxis of recurrent events
  - Anti-coagulant effects of direct thrombin inhibitors: compared for potential use in clinical practice
Jörg I. - Prophylaxis of recurrent thromboembolism in a patient with a history of heparin-induced thrombocytopenia with thrombosis, anti-lepirudin antibodies after Bjork-Shiley aortic valve implantation using fondaparinux
Jorgensen L. N. - Prolonged thromboprophylaxis with low molecular weight heparin (tinzaparin) following major general surgery primarily for cancer: An individual patient data meta-analysis
Jorgensen L. N. - Prolonged thromboprophylaxis with low molecular weight heparin (dalteparin) after major abdominal surgery: the FAME study
Jorneskog G. - Thrombin activatable fibrinolysis inhibitor (TAFI) and hemostatic changes in patients with type I diabetes mellitus with and without microvascular complications
Jorquera J. I. - Limited ability of nonactivated partial thromboplastin time to monitor clotting factors activation in high purity/high potency Factor IX concentrates
Joseph J. - A single-center prospective study of clinical and genetic thrombophilic risk factors for deep venous thrombosis (DVT) in 510 patients undergoing elective lower limb surgery
Joseph J. S. - Comparative molecular modeling of the nonenzymatic subunit of pseutarin C, a prothrombin activator from the venom of eastern brown snake
Joseph P. - Anti-thrombotic treatment after coronary artery bypass graft surgery (CABGS):economic consequence of a change in regimen
Joseph J. - Detection of procoagulants with a more reliable nonactivated clotting test
Joseph J. E. - Abciximab therapy post elective coronary artery stenting does not prevent a troponin rise mediated by increased levels of platelet P-selectin and platelet-monocyte aggregates
Joseph J. - Procoagulant phospholipid in blood normally associates mainly with cells or aggregates larger than microparticles or platelets
Joseph G. - Extrahepatic synthesis of coagulation factor VII in prostate and breast cancer
Joseph J. - Diagnostic utility of Simplify d-dimer – a new d-dimer test for patients with suspected venous thromboembolism
Joshi N. B. J. - Multimerin supports platelet adhesion by functioning as an RGD ligand for platelet integrin receptors
Joshi S. S. - Plasma tissue factor pathway inhibitor (TFPI) – A marker of severe coronary atherosclerosis
Jost M. - Plasminogen activator inhibitor PAI-1 as a regulator of urokinase in angiogenesis
Joubert J. E. H. - The use of the rotational thrombelastograph (ROTEG) in the quantification of the ‘lytic state’ during thrombolytic therapy: a comparative analysis in the subhuman primate
Joutsi-Korhonen L. - The low frequency allele of glycoprotein VI raises the threshold for platelet activation by collagen and collagen-related peptides
Joutsi-Korhonen L. - The epitope of the CD109 monoclonal antibody 8A3 overlaps with the epitope of Gov antibodies: implications for Gov antibody detection
Joutsi-Korhonen M.-L. - Functional significance of single-nucleotide polymorphisms in the glycoprotein VI gene
Joutsi-Korhonen L. - Human glycoprotein VI: identification and blockade of the collagen-binding surface
  - Platelet glycoprotein VI has evolutionary conserved immunoglobulin domains, but a highly polymorphic stem and cytoplasmic domain
Joyal F. - Resource utilization and loss of productivity during the 4 months following a diagnosis of deep venous thrombosis
Joyeux N. - Oral anti-coagulation in elderly patients in clinical practice: 187 patients
Jozefonvicz J. - Extracorporeal adsorption of Factor VIII antibodies on randomly functionalized polystyrene resins
Jozwiak M. A. - The sorting signal for von Willebrand factor (vWF) granular storage lies within the first 140 amino acids of the D2 domain of the VWF propeptide (VWFpp)
Juan O. - Local blockade of the collagen binding domain to vWF-A3 with Saratin decreases thrombotic risk in human atherosclerotic lesions
Jude B. - Effect of in vivo thrombin inhibition on bFGF-induced angiogenesis in a murine angiogenic model
  - Tissue factor predicts long-term outcome after percutaneous coronary revascularization
Jude B. - Tissue factor pathway in carotid atherosclerotic plaques: relationships with clinical patterns and risk factors
Juergens G. - Low inhibitor levels allow fast and sufficient thrombin generation in tissue factor-activated cord plasma
Juhan-Vague I. - Polymorphisms in the thrombomodulin gene as risk factors for myocardial infarction (HIFMECH study)
Juhan-Vague I. - Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk
Juhan-Vague I. - Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation
  - Transmembrane TNFa and wild-type TNFa differently modulate atherosclerotic process in mice
Julia P. - Factor II 20210 G-A but not Factor V Arg506Gln gene polymorphism is associated with peripheral arterial disease in a case-control study
Julian J. - Ability of d-dimer to reduce the need for diagnostic imaging in patients with suspected pulmonary embolism: A randomized trial
  - Central venous line-related thrombotic events in children: association with duration of line placement, type, size, and location
  - A systematic review of venous thromboembolism and long distance travel: strength of association and evidence for prevention
Julian J. A. - Long-term treatment with dalteparin low-molecular-weight heparin (LMWH) is more effective than oral anticoagulant (OA) therapy in cancer patients with venous thromboembolism (VTE)
  - Long-term treatment with dalteparin low-molecular-weight heparin (LMWH) may improve survival in patients with nonmetastatic malignancy and venous thromboembolism (VTE)
Julian J. - Influence of thrombophilia on efficacy of warfarin for prevention of recurrent venous thromboembolism: results from a randomized trial
  - Influence of warfarin use on symptoms of fatigue: a randomized cross-over trial
Jumilly A.-L. - Screening for annexin A5 gene mutations and the risk of the C-1T mutation in venous thrombosis and myocardial infarction
Jun C. - The clinical significance of TpP in patient with acute coronary syndrome
Juneau P. - Compound 48/80 inhibits thrombosis in balloon-injured arteries of hypercholesterolemic rabbits by inhibiting TF/FVIIa-mediated coagulation
Jung S. M. - Variation of GPVI levels in platelets: relationship to platelet function at high shear
  - VWF/FVIII concentrate enhances platelet adhesion onto a surface of immobilized collagen under flow conditions
Jung O. - Anti-endothelial cell antibodies (AECA): cDNA-based antigen screening
Jung K. - Age but not the presence of cancer predicts impairment of the protein C pathway in surgical patients
Jung-Im H. - Androgen receptor-mediated suppression of tissue factor gene expression in male reproductive organs
  - Nonmethylated status of promoter CpG islands in human tissue factor gene
Junker R. - Elevated factor VIIIC and further prothrombotic risk factors in paediatric venous thrombosis and stroke: a multivariate analysis
  - Sinus venous thrombosis in children – a multifactorial etiology
Junqueira-De-Azevedo I. L. M. - Recombinant Lopap (a prothrombin activator from Lonomia obliqua) has a very conservative structure of lipocalins
Jurek M. - The platelet ADP receptor P2Y12 is a critical player on the pathway of aIIbb3 activation by multiple agonists
Juri M. - Association between recurrent pregnancy loss and prothrombotic gene polymorphisms
Jurk K. - Thrombospondin-1 promotes transendothelial migration of monocytes associated with platelets
Juscinski J. - Changes in von Willebrand factor concentration and blood loss during cardiac surgery
Justiça B. - The prognostic value of platelet count drop in an intensive care unit
  - Coagulation inhibitor monitoring rationale in critical patients with severe sepsis
  - Glanzmann thrombasthenia: a study of two Portuguese families and identification of a new homozygous C insertion in exon 10 of the GPIIIa
Jy W. - Tissue factor activity is controlled by its inhibitor and redox state: Findings in endothelial microparticles, monocytes, and a porcine trauma model
  - Successful outcome of rituximab therapy for spontaneous refractory high titer FVIII inhibitors
  - Life-threatening thrombosis following splenectomy in a patient with ITP: successful management with anticoagulation and danazol